Mengis Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$1.46M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$942K |
| 3 |
Air Products & Chemicals
APD
|
+$565K |
| 4 |
GE HealthCare
GEHC
|
+$393K |
| 5 |
NVIDIA
NVDA
|
+$390K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$32.8M |
| 2 |
PACCAR
PCAR
|
+$31.9M |
| 3 |
Apple
AAPL
|
+$14.8M |
| 4 |
Costco
COST
|
+$9.57M |
| 5 |
Woodward
WWD
|
+$4.96M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.06% |
| 2 | Industrials | 16.94% |
| 3 | Healthcare | 13.95% |
| 4 | Consumer Staples | 9.16% |
| 5 | Energy | 7.07% |
Similar funds
Mengis Capital Management's Q2 2024 Portfolio in Review
As of Q2 2024, Mengis Capital Management held 223 positions worth $493M, down 24% from $649M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Mengis Capital Management withdrew a net $153M in Q2 2024, closing 43 positions and reducing 125 holdings. Its most notable exit was St. Joe Company, an estimated $1.82M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Mengis Capital Management opened a new position in Air Products & Chemicals worth $575K.
- Mengis Capital Management's largest Q2 2024 buy was Air Products & Chemicals: 2,228 shares worth $575K.
- Mengis Capital Management added most to Medtronic in Q2 2024, an estimated $1.46M increase.
- Mengis Capital Management's biggest Q2 2024 reduction was Microsoft, cutting an estimated $32.8M.
- Mengis Capital Management fully exited St. Joe Company in Q2 2024, selling an estimated $1.82M.
- Mengis Capital Management's ten largest holdings make up 37% of its $493M portfolio in Q2 2024.
- Mengis Capital Management opened 7 new positions and closed 43 in Q2 2024.
- Mengis Capital Management's portfolio value fell 24% quarter-over-quarter to $493M.
Based on Mengis Capital Management's 13F filing for Q2 2024, filed 17 Jul 2024.